Diagnosis and treatment of pyoderma gangrenosum

British Medical Journal

Volumn 333, Issue 7560, 2006, Pages 181-184

  Brooklyn, Trevor ^a   Dunnill, Giles ^b   Probert, Chris ^b  

^a CHELTENHAM GENERAL HOSPITAL   (United Kingdom)

^b BRISTOL ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID DERIVATIVE; CYCLOSPORIN A; ETANERCEPT; INFLIXIMAB; METHYLPREDNISOLONE; MINOCYCLINE; PREDNISOLONE; TACROLIMUS; TRIAMCINOLONE; IMMUNOSUPPRESSIVE AGENT;

ACUTE FEBRILE NEUTROPHILIC DERMATOSIS; CANCER; CANCER RISK; CLINICAL FEATURE; CLINICAL TRIAL; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG DOSAGE FORM; HEMATOLOGIC MALIGNANCY; HISTOPATHOLOGY; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; NEPHROTOXICITY; PRIORITY JOURNAL; PYODERMA GANGRENOSUM; REVIEW; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; BIOPSY; EARLY DIAGNOSIS; PATHOLOGY; SKIN;

BIOPSY; EARLY DIAGNOSIS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; PYODERMA GANGRENOSUM; SKIN;

EID: 33746319458     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.333.7560.181     Document Type: Review

References (25)

1. Harris AJ, Regan P, Burge S. Early diagnosis of pyoderma gangrenosum is important to prevent disfigurement. BMJ 1998;316:52-3.
2. Bennett ML, Jackson JM, Jorizzo JL, Fleischer AB Jr, White WL, Callen JP. Pyoderma gangrenosum. A comparison of typical and atypical forms with an emphasis on time to remission. Case review of 86 patients from 2 institutions. Medicine (Baltimore) 2000;79:37-46.
3. Lyon CC, Smith AJ, Beck MH, Wong GA, Griffiths CE. Parastomal pyoderma gangrenosum: clinical features and management. J Am Acad Dermatol 2000;42:992-1002.
4. Lyon CC, Smith AJ, Griffiths CE, Beck MH. The spectrum of skin disorders in abdominal stoma patients. Br J Dermatol 2000;143:1248-60.
5. Lyon CC, Stapleton M, Smith AJ, Mendelsohn S, Beck MH, Griffiths CE. Topical tacrolimus in the management of peristomal pyoderma gangrenosum. J Dermatol Treat 2001;12:13-7.
6. Fenske NA, Gern JK, Pierce D, Vasey FB. Vesiculopustular eruption of ulcerative colitis. Arch Dermatol 1983;119:664-9.
7. Callen JP, Woo TY. Vesiculopustular eruption in a patient with ulcerative colitis. Pyoderma gangrenosum. Arch Dermatol 1985;121:399, 402.
8. Powell FC, Collins S. Pyoderma gangrenosum. Clin Dermatol 2000;18:283-93.
9. Hay CR, Messenger AG, Cotton DW, Bleehen SS, Winfield DA. Atypical bullous pyoderma gangrenosum associated with myeloid malignancies. J Clin Pathol 1987;40:387-92.
10. Wilson-Jones E, Winkelmann RK. Superficial granulomatous pyoderma: a localized vegetative form of pyoderma gangrenosum. J Am Acad Dermatol 1988;18:511-21.
11. Su WP Schroeter AL, Perry HO, Powell FC. Histopathologic and immunopathologic study of pyoderma gangrenosum. J Cutan Pathol 1986;13:323-30.
12. Callen JP. Pyoderma gangrenosum. Lancet 1998;351:581-5.
13. Thornton JR, Teague RH, Low-Beer TS, Read AF. Pyoderma gangrenosum and ulcerative colitis. Gut 1980;21:247-8.
14. Von den Driesch P. Pyoderma gangrenosum: a report of 44 cases with follow-up. Br J Dermatol 1997;137:1000-5.
15. Duguid CM, Powell FC. Pyoderma gangrenosum. Clin Dermatol 1993;11:129-33.
16. Reichrath J, Bens G, Bonowitz A, Tilgen W. Treatment recommendations for pyoderma gangrenosum: an evidence-based review of the literature based on more than 350 patients. J Am Acad Dermatol 2005;53:273-83.
17. Hughes AP, Jackson JM, Callen JP. Clinical features and treatment of peristomal pyoderma gangrenosum. JAMA 2000;284:1546-8.
18. Berth-Jones J, Tan SV, Graham-Brown RAC, Pembroke AC. The successful use of minocycline in pyoderma gangrenosum - a report of seven cases and review of the literature. J Dermatol Treat 1989;1:23-5.
19. Johnson RB, Lazarus GS. Pulse therapy. Therapeutic efficacy in the treatment of pyoderma gangrenosum. Arch Dermatol 1982;118:76-84.
20. Friedman S, Marion JF, Scherl E, Rubin PH, Present DH. Intravenous cyclosporine in refractory pyoderma gangrenosum complicating inflammatory bowel disease. Inflamm Bowel Dis 2001;7:1-7.
21. Lyon CC, Kirby B, Griffiths CE. Recalcitrant pyoderma gangrenosum treated with systemic tacrolimus. Br J Dermatol 1999;140:562-4.
22. Regueiro M, Valentine J, Plevy S, Fleisher MR, Lichtenstein GR. Infliximab for treatment of pyoderma gangrenosum associated with inflammatory bowel disease. Am J Gastroenterol 2003;98:1821-6.
23. McGowan JW, Johnson CA, Lynn A. Treatment of pyoderma gangrenosum with etanercept. J Drugs Dermatol 2004;3:441-4.
24. Brooklyn TN, Dunnill MG, Shetty A, Bowden JJ, Williams JD, Griffiths CE, et al. Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial. Gut 2006;55:505-9.
25. Hanauer SB, Feagan BG, Lichtenstein GR, Mayer LF, Schreiber S, Colombel JF, et al. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial. Lancet 2002;359:1541-9.